576
|
Kuo S, Chen L, Wu M, Hsu C, Lin C, Hsu P, Yeh K, Tzeng Y, Cheng A. Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide—the molecular mechanism and the clinical application. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e19512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e19512 Background: We have recently demonstrated that nuclear expression of BCL10 or NF-κB helps predict H. pylori-independent status; and inflammatory cytokines such as TNF-α may be related to BCL10 nuclear translocation (Blood 2005;106:1037–41;J Biol Chem 2006;281:167–75). Recent studies have been shown that the chimeric protein of t(11;18)(q21;q21) can lead to constitutive NF-κB activity and thereby mediate cell survival and anti-apoptotic signals. The present study was conducted to investigate the molecular mechanism and the clinical efficacy of thalidomide, an TNF-α or NF-κB inhibitor, in H. pylori-independent MALT lymphoma. Methods: Between October 2003 and June 2007, our study enrolled 11 H. pylori-independent MALT lymphoma patients ( 7 men and 4 women; age range, 43 to 79 years; 7 patients who had failed chemotherapy or rituximab) with nuclear expression of BCL10 or NF-κB in pretreatment lymphoma tissues treated at National Taiwan University Hospital with thalidomide 100mg to 200 mg oral given daily. The presence of t(11;18)(q21;q21) was identified by a multiplex reverse transcriptase polymerase chain reaction of the API2-MALT1 chimeric transcript. Results: Three (27.3%) of 11 patients achieved a complete response (CR), and 3 (27.3) of 11 patients achieved a partial response (PR), resulting in an overall response rate of 54.5% (95% CI, 19.5%-89.6%). The median time from thalidomide therapy to CR was 3.0 months (range, 2.7–4.9 months). At a median follow-up of 41.6 months (range, 17.7–63.8 months), the 3-year event-free survival and overall survival after thalidomide treatment was 80.8%, and 88.9%, respectively. The API2-MALT1 fusion transcript for t(11;18)(q21;q21) was detected in 1 (16.7%) of 6 patients with CR or PR, and 4 (80.0%) of 5 patients with stable or progressive disease (P = 0.08). Conclusions: Our results indicate that thalidomide can be an adjuvant treatment for H. pylori-independent MALT lymphoma patients. Additional investigation of the molecular mechanisms and biologic significance of the API2-MALT1 fusion transcript responsible for thalidomide resistance in this group of tumors is needed. No significant financial relationships to disclose.
Collapse
|
577
|
Yeh K, Hsu C, Hsu C, Lin C, Shen Y, Wu S, Chiou T, Chao Y, Cheng A. Phase II study of cetuximab plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for the first-line treatment of advanced gastric cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.4567] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4567 Background: Cisplatin-HDFL regimen, using weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil (5-FU) and leucovorin, is commonly used in Taiwan for patients with advanced gastric cancer (GC), showing an overall response rate of approximately 60% (95% CI: 45%-76%) [J Clin Oncol (Suppl) 2006; 24(18S): A14063 ]. We have demonstrated that cetuximab is cytotoxic to human GC cells, and has a chemosensitizing effect for cisplatin and 5-FU in GC cells [Proc AACR 2006; 47: A1233]. Methods: All patients had pathologically confirmed metastatic/ recurrent chemonaive GC, at least 1 measurable lesion, a fasting serum triglyceride level > 70 mg/dl, WHO PS 0/1/2, adequate hepatic, renal, and bone marrow functions. Cetuximab 400 mg/m2 was given as 2h infusion, initially (i.e., D1 of cycle 1); and followed by weekly 1h infusion of 250 mg/m2 (i.e., D8, D15, D22 of cycle 1, and D1, D8, D15, D22 of cycle 2). Cisplatin 35 mg/m2 was given as a 24h infusion, admixing with 5-FU 2,000 mg/m2 and leucovorin 300 mg/m2 (HDFL), D1, D8. A 24h infusion of HDFL was given on D15. Cycles were repeated every 28 days, and response evaluation was performed every 2 cycles & at the end of protocol treatment. The primary end-point was confirmed objective response rate (RR) by RECIST. Results: Between Dec. 2005 and Nov. 2008, 35 patients (M:19, F:16) with a median age of 56 (40–74) were enrolled and evaluable for response assessment. The overall RR was 68.6% (51–83%, 95% C.I.) with 1 CR and 23 PRs. Among a total of 269 cycles (median: 7, range: 2 to 22+ cycles) given, Gr3/4 neutropenia, infection, and hepatic toxicity developed in 6.0%, 4.8%, and 0.74% of 269 cycles, respectively. Two patients have developed acute hepatitis B flare-up among seven HBsAg (+) carriers, and were well controlled by lamivudine. Gr1, Gr2, and Gr3 acne- like rashes have developed in 57.1%, 31.4%, 5.7%; and Gr1, Gr2, Gr3 paronychia have developed in 40.0%, 8.6%, and 2.9% of 35 patients, respectively. Median PFS (range: 3 to 22+ months) and median OS (range: 3 to 35+ months) was11.0 and 14.5 months, respectively. Conclusions: Cetuximab plus infusional cisplatin-HDFL is a highly effective regimen with low toxicity and favourable survival in the first-line treatment of advanced GC. No significant financial relationships to disclose.
Collapse
|
578
|
Roccaro AM, Sacco A, Leleu X, Thompson B, Azab A, Runnels J, Lin C, Witzig T, Anderson K, Ghobrial I. MicroRNAs 15a and 16–1 regulates tumor proliferation in multiple myeloma. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e14640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e14640 Background: MicroRNAs (miRNAs) are non-coding RNAs that act as negative regulators of gene expression. They have been described to play roles in solid tumors and hematologic malignancies. However the role of miRNAs in multiple myeloma (MM) has not been yet fully described. Methods: We performed miRNA-profiling of primary bone marrow-derived CD138+ MM cells, compared to their normal cellular counterparts and validated data by qRT-PCR. In vitro and in vivo functional studies were performed on miRNA-15a- and -16–1-precursors-transfected MM cells. Effect of miRNA-15a and -16–1 on signaling cascades have been evaluated by western blot and immunofluorescence. NF-kB activity has been studied using the Active Motif TransAM kit. In vivo MM cell growth has been evaluated by either using an in vivo imaging model or bioluminescence. Angiogenesis has been studied both in vitro and in vivo using the chorioallantoic membrane model. Results: We identified a MM-specific miRNA signature characterized by down-expression of miRNA-15a, -16–1 and over-expression of miRNA-222/-221/-382/-181a/-181b (P<0.01). Data were confirmed by qRT-PCR on matched samples. Predicted targets for the decreased miRNAs in MM patients included pro-angiogenic cytokines, oncogenes, cell cycle regulators, NFkB activators. Conversely, predicted targets for the increased miRNAs included cell cycle inhibitors, suppressors of cytokine signaling, and pro-apoptotic factors. We demonstrated that miRNA-15a and - 16–1 regulate proliferation and growth of MM cells. Indeed, transfected cells showed decreased DNA synthesis; decreased cyclinD1/cyclinD3/CDC25a/pRb protein expression; phase G1 cell cycle arrest. Moreover, transfected cells showed inhibition of NFkB pathway as shown by reduced p65-/p50-/p52-NFkB activities; downregulation of p-p65/p50/p52 nuclear protein level; upregulation of cttosolic phospho-IkB; and inhibited translocation of p-p65 from the cytolplasm to the nucleus. Similarly, inhibition of MM cell growth was confirmed in vivo; and anti-angiogenic properties of miRNA-15a and -16–1 were demonstrated both in vitro and in vivo. Conclusions: These data indicate that miRNAs play a pivotal role in the biology of MM; providing the basis for the development of new miRNA-based targeted therapies in this disease. No significant financial relationships to disclose.
Collapse
|
579
|
Dupuis J, Itti E, Rahmouni A, Hemery F, Gisselbrecht C, Lin C, Copie-Bergman C, Belhadj K, El Gnaoui T, Gaillard I, Kuhnowski F, Meignan M, Haioun C. Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria. Ann Oncol 2009; 20:503-7. [DOI: 10.1093/annonc/mdn671] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
580
|
Lin C, Zhang T, Rawson DM. Cryopreservation of zebrafish (Danio rerio) blastomeres by controlled slow cooling. CRYO LETTERS 2009; 30:132-141. [PMID: 19448862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Cryopreservation is now a common practice in the fields of aquaculture, conservation and biomedicine. One approach for maintaining the genetic diversity of both nuclear genome and mitochondrial DNA is cryopreservation of the blastomere. This study sets out to determine an optimum cryopreservation protocol for blastomeres isolated from 50% epiboly zebrafish embryos. Freezing was performed in 0.25 ml straws in a programmable freezer. The optimum slow cooling protocol is identified as 5 degree C per min, from 22 to -6 degree C, holding for 15 min, 0.3 degree C per min from -6 to -40 degree C, 2 degree C per min from -40 to -80 degree C, cells were held for 10 min at -80 degree C before plunging into the liquid nitrogen. Thawing was performed in a water bath at 28 degrees C for 15 s followed by four step-wise removal of the cryoprotectant. Blastomeres had the highest survival level (70.2 +/- 3.2%) when a mixture of 1.5 M dimethyl sulfoxide (DMSO) and 0.1 M sucrose were used as cryoprotectants. This was higher than that achieved with either of the sugar alternatives, trehalose (60.6 +/- 3.1%) or glucose (43.1 +/- 4.9%). In the present study, cryopreservation of 50 percent epiboly zebrafish blastomeres was studied for the first time using controlled slow cooling method.
Collapse
|
581
|
Lin C, Spikings E, Zhang T, Rawson D. Housekeeping genes for cryopreservation studies on zebrafish embryos and blastomeres. Theriogenology 2009; 71:1147-55. [PMID: 19201018 DOI: 10.1016/j.theriogenology.2008.12.013] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2008] [Revised: 12/10/2008] [Accepted: 12/10/2008] [Indexed: 11/19/2022]
Abstract
Cryopreservation success is usually analysed in terms of cell survival, although there are other potential effects that do not necessarily result in cell death. These include DNA damage, which could result in altered gene expression. Real-time reverse transcriptase PCR allows quantitative analysis of gene expression but usually requires analysis of a 'housekeeping' gene as an internal reference. As the stability of housekeeping genes varies significantly among different groups of samples, it is recommended that those chosen are validated for each different type of sample group. This study aimed to validate housekeeping genes for use in cryopreservation studies of zebrafish embryos. Seven potential housekeeping genes were analysed across fresh and chilled intact embryos and across fresh and frozen isolated blastomeres using the GeNorm and NormFinder software packages. Results suggest that combined use of beta-actin and EF1alpha as housekeeping genes would be suitable for cryopreservation studies on zebrafish embryos and blastomeres.
Collapse
|
582
|
Ho Y, Huang Y, Lin C, Chung C, Lin Y. Application of Radiofrequency Ablation of Renal VX2Tumors by Cooled-Tip Electrode in a Rabbit Model. IEEE Trans Nanobioscience 2009:1-1. [PMID: 19193521 DOI: 10.1109/tnb.2008.2011853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Objective. This study has two purposes: (a) to compare the use of tumor cell suspensions and excised tumor tissue for generating renal tumors suitable for radiofrequency ablation (RFA) studies and (b) to assess the efficacy of RFA for ablation of renal VX2 tumors in a rabbit model. Procedures. VX2 tumor masses were used to inoculate 17 rabbits. The renal VX2 tumors of 13 rabbits were subsequently treated with a cooled-tip RF system at a power of 15-30 W for 3-6 minutes, and 4 rabbits served as control. After RFA, rabbits were observed by contrast-enhanced CT to ascertain the ablative range. Rabbits were divided into three groups and sacrificed at 3, 7, and 14 days post-treatment for histopathological studies. Results. Both tumor implant methods had a 100% success rate in generating tumors. The average lesion produced was 1.3x1.8x1.5 cm. Complete tumor ablation occurred in 76.9%, and local tumor growth in 23.1%. Depending on the position of the tumors, the complications after RFA treatment included infarction, perirenal hematoma, hydronephrosis, and abscess. The over-all complication rate was 38.5%. In histopathological studies, a central needle track, tumor coagulation, renal tissue coagulation, peripheral hemorrhage, and an inflammatory layer could be observed. Conclusion and clinical relevance. Application of RFA to destroy renal VX2 tumors in this rabbit model has a relatively high cure rate. It can be used to destroy small renal tumors in a precise and non-invasive manner. Impact on human medicine. We hope to apply this procedure in selected human renal tumors in the future.
Collapse
|
583
|
Wang Q, Gong L, Dong R, Qiao Q, He XL, Chu YK, Du XL, Yang Y, Zang L, Nan J, Lin C, Lu JG. Tissue Microarray Assessment of Selenoprotein P Expression in Gastric Adenocarcinoma. J Int Med Res 2009; 37:169-74. [PMID: 19215687 DOI: 10.1177/147323000903700120] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
This study investigated selenoprotein P expression, using immunohistochemistry, in gastric adenocarcinoma tissue microarrays constructed from 30 gastric adenocarcinoma specimens and 30 normal gastric tissues (controls). Selenoprotein P expression scores were significantly lower in gastric adenocarcinoma (17/30, 56.7%) than in control tissues (25/30, 83.3%). Selenoprotein P was significantly more likely to be expressed in well-to-moderately differentiated cases (13/17, 76.5%) than in cases with low differentiation (4/13, 30.8%) and there was no significant difference in selenoprotein P expression between tumour node metastasis (TNM) stage I – II (11/19, 57.9%) and TNM stage III (6/11, 54.5%). In conclusion, selenoprotein P expression was low in gastric adenocarcinoma tissues compared with control tissues and was related to the degree of gastric adenocarcinoma differentiation but not to TNM stage.
Collapse
|
584
|
Aaltonen T, Adelman J, Akimoto T, Albrow MG, Alvarez González B, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Aoki M, Apollinari G, Apresyan A, Arisawa T, Artikov A, Ashmanskas W, Attal A, Aurisano A, Azfar F, Azzi-Bacchetta P, Azzurri P, Bacchetta N, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Baroiant S, Bar-Shalom S, Bartsch V, Bauer G, Beauchemin PH, Bedeschi F, Bednar P, Behari S, Bellettini G, Bellinger J, Belloni A, Benjamin D, Beretvas A, Beringer J, Berry T, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bolla G, Bolshov A, Bortoletto D, Boudreau J, Boveia A, Brau B, Bridgeman A, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Campanelli M, Campbell M, Canelli F, Canepa A, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Choudalakis G, Chuang SH, Chung K, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark A, Clark D, Compostella G, Convery ME, Conway J, Cooper B, Copic K, Cordelli M, Cortiana G, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Cully JC, Dagenhart D, Datta M, Davies T, de Barbaro P, De Cecco S, Deisher A, De Lentdecker G, De Lorenzo G, Dell'orso M, Demortier L, Deng J, Deninno M, De Pedis D, Derwent PF, Di Giovanni GP, Dionisi C, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Donini J, Dorigo T, Dube S, Efron J, Erbacher R, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Forrester S, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garfinkel AF, Genser K, Gerberich H, Gerdes D, Giagu S, Giakoumopolou V, Giannetti P, Gibson K, Gimmell JL, Ginsburg CM, Giokaris N, Giordani M, Giromini P, Giunta M, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Grundler U, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hamilton A, Han BY, Han JY, Handler R, Happacher F, Hara K, Hare D, Hare M, Harper S, Harr RF, Harris RM, Hartz M, Hatakeyama K, Hauser J, Hays C, Heck M, Heijboer A, Heinemann B, Heinrich J, Henderson C, Herndon M, Heuser J, Hewamanage S, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Husemann U, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, Iyutin B, James E, Jayatilaka B, Jeans D, Jeon EJ, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Kar D, Karchin PE, Kato Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Klute M, Knuteson B, Ko BR, Koay SA, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kraus J, Kreps M, Kroll J, Krumnack N, Kruse M, Krutelyov V, Kubo T, Kuhlmann SE, Kuhr T, Kulkarni NP, Kusakabe Y, Kwang S, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, Lecompte T, Lee J, Lee J, Lee YJ, Lee SW, Lefèvre R, Leonardo N, Leone S, Levy S, Lewis JD, Lin C, Lin CS, Linacre J, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu T, Lockyer NS, Loginov A, Loreti M, Lovas L, Lu RS, Lucchesi D, Lueck J, Luci C, Lujan P, Lukens P, Lungu G, Lyons L, Lys J, Lysak R, Lytken E, Mack P, Macqueen D, Madrak R, Maeshima K, Makhoul K, Maki T, Maksimovic P, Malde S, Malik S, Manca G, Manousakis A, Margaroli F, Marino C, Marino CP, Martin A, Martin M, Martin V, Martínez M, Martínez-Ballarín R, Maruyama T, Mastrandrea P, Masubuchi T, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Miao T, Miladinovic N, Miles J, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello M, Movilla Fernandez P, Mülmenstädt J, Mukherjee A, Muller T, Mumford R, Murat P, Mussini M, Nachtman J, Nagai Y, Nagano A, Naganoma J, Nakamura K, Nakano I, Napier A, Necula V, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norman M, Norniella O, Nurse E, Oh SH, Oh YD, Oksuzian I, Okusawa T, Oldeman R, Orava R, Osterberg K, Pagan Griso S, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramonov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pinera L, Pitts K, Plager C, Pondrom L, Portell X, Poukhov O, Pounder N, Prakoshyn F, Pronko A, Proudfoot J, Ptohos F, Punzi G, Pursley J, Rademacker J, Rahaman A, Rajaraman A, Ramakrishnan V, Ranjan N, Redondo I, Reisert B, Rekovic V, Renton P, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Roy P, Ruiz A, Russ J, Rusu V, Saarikko H, Safonov A, Sakumoto WK, Salamanna G, Saltó O, Santi L, Sarkar S, Sartori L, Sato K, Savoy-Navarro A, Scheidle T, Schlabach P, Schmidt EE, Schmidt MA, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scott AL, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sfyria A, Shalhout SZ, Shapiro MD, Shears T, Shepard PF, Sherman D, Shimojima M, Shochet M, Shon Y, Shreyber I, Sidoti A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soderberg M, Soha A, Somalwar S, Sorin V, Spalding J, Spinella F, Spreitzer T, Squillacioti P, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Stuart D, Suh JS, Sukhanov A, Sun H, Suslov I, Suzuki T, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tecchio M, Teng PK, Terashi K, Thom J, Thompson AS, Thompson GA, Thomson E, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Tourneur S, Trischuk W, Tu Y, Turini N, Ukegawa F, Uozumi S, Vallecorsa S, van Remortel N, Varganov A, Vataga E, Vázquez F, Velev G, Vellidis C, Veszpremi V, Vidal M, Vidal R, Vila I, Vilar R, Vine T, Vogel M, Volobouev I, Volpi G, Würthwein F, Wagner P, Wagner RG, Wagner RL, Wagner-Kuhr J, Wagner W, Wakisaka T, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wright T, Wu X, Wynne SM, Yagil A, Yamamoto K, Yamaoka J, Yamashita T, Yang C, Yang UK, Yang YC, Yao WM, Yeh GP, Yoh J, Yorita K, Yoshida T, Yu GB, Yu F, Yu I, Yu SS, Yun JC, Zanello L, Zanetti A, Zaw I, Zhang X, Zheng Y, Zucchelli S. Search for maximal flavor violating scalars in same-charge lepton pairs in pp collisions at sqrt[s]=1.96 TeV. PHYSICAL REVIEW LETTERS 2009; 102:041801. [PMID: 19257412 DOI: 10.1103/physrevlett.102.041801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/29/2008] [Indexed: 05/27/2023]
Abstract
Models of maximal flavor violation (MxFV) in elementary particle physics may contain at least one new scalar SU(2) doublet field Phi(FV)=(eta(0),eta(+)) that couples the first and third generation quarks (q_(1), q_(3)) via a Lagrangian term L(FV)=xi(13)Phi(FV)q(1)q(3). These models have a distinctive signature of same-charge top-quark pairs and evade flavor-changing limits from meson mixing measurements. Data corresponding to 2 fb(-1) collected by the Collider Dectector at Fermilab II detector in pp[over ] collisions at sqrt[s]=1.96 TeV are analyzed for evidence of the MxFV signature. For a neutral scalar eta(0) with m_(eta;(0))=200 GeV/c(2) and coupling xi(13)=1, approximately 11 signal events are expected over a background of 2.1+/-1.8 events. Three events are observed in the data, consistent with background expectations, and limits are set on the coupling xi(13) for m(eta(0)=180-300 GeV/c(2).
Collapse
|
585
|
Lin C, Turner S, Gurney H, Peduto A. Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: an effect of improved systemic therapy? J Med Imaging Radiat Oncol 2009; 52:376-81. [PMID: 18811763 DOI: 10.1111/j.1440-1673.2008.01973.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Metastases from prostate cancer occur largely in bone through a haematogenous route. Metastatic spread of prostate cancer to the leptomeninges was rarely seen in the past. However, there has been a recent increase in presentations of leptomeningeal spread from prostate cancer in our institutions. Between 2004 and 2006, four patients were diagnosed with metastatic prostate cancer with leptomeningeal metastases in our centres. All four patients had hormone refractory prostate cancer and had previously had chemotherapy. The median survival of these patients was approximately 15 months from the time of hormone refractoriness. The prognosis of leptomeningeal metastasis secondary to metastatic prostate cancer is poor, ranging from 2 to 7 months as seen in our series. New cases of leptomeningeal metastases seen in our series are hypothesized to be secondary to the use of effective modern systemic treatments. A parallel might be drawn with the increased rate of central nervous system metastases in breast cancer since the introduction of effective cytotoxic treatments and more recently targeted therapies. We suggest the clinicians to be aware of the potential change of natural history and pattern of progression in metastatic prostate cancer.
Collapse
|
586
|
Lin C, Edwards C, Armstrong G, Patel H, Scott T, Hart HH, Christiansen JP. Left Ventricular Dysfunction in Patients Presenting With Acute Atrial Fibrillation: The Importance of Rate-Related Cardiomyopathy. Heart Lung Circ 2009. [DOI: 10.1016/j.hlc.2009.04.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
587
|
Hsu YF, Lin C, Chen DR. Nandrolone abuse aggravates septic shock. Crit Care 2009. [PMCID: PMC2776177 DOI: 10.1186/cc8060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
588
|
Liu H, Yu X, Li K, Klejnot J, Yang H, Lisiero D, Lin C. Photoexcited CRY2 Interacts with CIB1 to Regulate Transcription and Floral Initiation in Arabidopsis. Science 2008; 322:1535-9. [DOI: 10.1126/science.1163927] [Citation(s) in RCA: 506] [Impact Index Per Article: 31.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
589
|
Lin C, Zhong Z, Lok M, de Wolf HK, Hennink W, Feijen J, Engbersen J. Bioreducible poly(amido amine)s for gene delivery to ovarian cancer cells. J Control Release 2008. [DOI: 10.1016/j.jconrel.2008.09.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
590
|
Piest M, Lin C, Mateos-Timoneda M, Lok M, Hennink W, Feijen J, Engbersen J. Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: Structure effects and in vitro gene transfer properties. J Control Release 2008. [DOI: 10.1016/j.jconrel.2008.09.047] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
591
|
Jean S, Hsueh P, Lee W, Chang H, Chou M, Wang I, Wang J, Lin C, Shyr J, Ko W, Wu J, Liu Y, Huang W, Teng L, Liu C. Nationwide Surveillance of Doripenem Susceptibility among Clinical Isolates in intensive care units in Taiwan: SMART Program 2004 data. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.1049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
592
|
Aaltonen T, Adelman J, Akimoto T, Albrow MG, Alvarez González B, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Aoki M, Apollinari G, Apresyan A, Arisawa T, Artikov A, Ashmanskas W, Attal A, Aurisano A, Azfar F, Azzi-Bacchetta P, Azzurri P, Bacchetta N, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Baroiant S, Bartsch V, Bauer G, Beauchemin PH, Bedeschi F, Bednar P, Behari S, Bellettini G, Bellinger J, Belloni A, Benjamin D, Beretvas A, Beringer J, Berry T, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bolla G, Bolshov A, Bortoletto D, Boudreau J, Boveia A, Brau B, Bridgeman A, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Campanelli M, Campbell M, Canelli F, Canepa A, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Choudalakis G, Chuang SH, Chung K, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark A, Clark D, Compostella G, Convery ME, Conway J, Cooper B, Copic K, Cordelli M, Cortiana G, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Cully JC, Dagenhart D, Datta M, Davies T, de Barbaro P, De Cecco S, Deisher A, De Lentdecker G, De Lorenzo G, Dell'Orso M, Demortier L, Deng J, Deninno M, De Pedis D, Derwent PF, Di Giovanni GP, Dionisi C, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Donini J, Dorigo T, Dube S, Efron J, Erbacher R, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Forrester S, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garfinkel AF, Genser K, Gerberich H, Gerdes D, Giagu S, Giakoumopolou V, Giannetti P, Gibson K, Gimmell JL, Ginsburg CM, Giokaris N, Giordani M, Giromini P, Giunta M, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Grundler U, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hamilton A, Han BY, Han JY, Handler R, Happacher F, Hara K, Hare D, Hare M, Harper S, Harr RF, Harris RM, Hartz M, Hatakeyama K, Hauser J, Hays C, Heck M, Heijboer A, Heinemann B, Heinrich J, Henderson C, Herndon M, Heuser J, Hewamanage S, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Husemann U, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, Iyutin B, James E, Jayatilaka B, Jeans D, Jeon EJ, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Kar D, Karchin PE, Kato Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Klute M, Knuteson B, Ko BR, Koay SA, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kraus J, Kreps M, Kroll J, Krumnack N, Kruse M, Krutelyov V, Kubo T, Kuhlmann SE, Kuhr T, Kulkarni NP, Kusakabe Y, Kwang S, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, LeCompte T, Lee J, Lee J, Lee YJ, Lee SW, Lefèvre R, Leonardo N, Leone S, Levy S, Lewis JD, Lin C, Lin CS, Linacre J, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu T, Lockyer NS, Loginov A, Loreti M, Lovas L, Lu RS, Lucchesi D, Lueck J, Luci C, Lujan P, Lukens P, Lungu G, Lyons L, Lys J, Lysak R, Lytken E, Mack P, MacQueen D, Madrak R, Maeshima K, Makhoul K, Maki T, Maksimovic P, Malde S, Malik S, Manca G, Manousakis A, Margaroli F, Marino C, Marino CP, Martin A, Martin M, Martin V, Martínez M, Martínez-Ballarín R, Maruyama T, Mastrandrea P, Masubuchi T, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Miao T, Miladinovic N, Miles J, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello M, Movilla Fernandez P, Mülmenstädt J, Mukherjee A, Muller T, Mumford R, Murat P, Mussini M, Nachtman J, Nagai Y, Nagano A, Naganoma J, Nakamura K, Nakano I, Napier A, Necula V, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norman M, Norniella O, Nurse E, Oh SH, Oh YD, Oksuzian I, Okusawa T, Oldeman R, Orava R, Osterberg K, Pagan Griso S, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramonov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pinera L, Pitts K, Plager C, Pondrom L, Portell X, Poukhov O, Pounder N, Prakoshyn F, Pronko A, Proudfoot J, Ptohos F, Punzi G, Pursley J, Rademacker J, Rahaman A, Ramakrishnan V, Ranjan N, Redondo I, Reisert B, Rekovic V, Renton P, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Roy P, Ruiz A, Russ J, Rusu V, Saarikko H, Safonov A, Sakumoto WK, Salamanna G, Saltó O, Santi L, Sarkar S, Sartori L, Sato K, Savoy-Navarro A, Scheidle T, Schlabach P, Schmidt EE, Schmidt MA, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scott AL, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sfyrla A, Shalhout SZ, Shapiro MD, Shears T, Shepard PF, Sherman D, Shimojima M, Shochet M, Shon Y, Shreyber I, Sidoti A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soderberg M, Soha A, Somalwar S, Sorin V, Spalding J, Spinella F, Spreitzer T, Squillacioti P, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Stuart D, Suh JS, Sukhanov A, Sun H, Suslov I, Suzuki T, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tecchio M, Teng PK, Terashi K, Thom J, Thompson AS, Thompson GA, Thomson E, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Tourneur S, Trischuk W, Tu Y, Turini N, Ukegawa F, Uozumi S, Vallecorsa S, van Remortel N, Varganov A, Vataga E, Vázquez F, Velev G, Vellidis C, Veszpremi V, Vidal M, Vidal R, Vila I, Vilar R, Vine T, Vogel M, Volobouev I, Volpi G, Würthwein F, Wagner P, Wagner RG, Wagner RL, Wagner-Kuhr J, Wagner W, Wakisaka T, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wright T, Wu X, Wynne SM, Yagil A, Yamamoto K, Yamaoka J, Yamashita T, Yang C, Yang UK, Yang YC, Yao WM, Yeh GP, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanello L, Zanetti A, Zaw I, Zhang X, Zheng Y, Zucchelli S. Search for doubly charged Higgs bosons with lepton-flavor-violating decays involving tau leptons. PHYSICAL REVIEW LETTERS 2008; 101:121801. [PMID: 18851361 DOI: 10.1103/physrevlett.101.121801] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/07/2007] [Indexed: 05/26/2023]
Abstract
We search for pair production of doubly charged Higgs particles (H+/- +/-) followed by decays into electron-tau (etau) and muon-tau (mutau) pairs using data (350 pb(-1) collected from [over]pp collisions at sqrt[s]=1.96 TeV by the CDF II experiment. We search separately for cases where three or four final-state leptons are detected, and combine results for exclusive decays to left-handed etau (mutau) pairs. We set an H+/- +/- lower mass limit of 114(112) GeV/c(2) at the 95% confidence level.
Collapse
|
593
|
Fan K, Chang J, Liao C, Chen I, Lin C, Chen Y. Presence of Single Minor Risk is not an Indication for Adjuvant Radiotherapy: Retrospective Analysis of the Treatment Result of Oral Cavity Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 2008. [DOI: 10.1016/j.ijrobp.2008.06.1290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
594
|
Aaltonen T, Adelman J, Akimoto T, Albrow MG, Alvarez González B, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Aoki M, Apollinari G, Apresyan A, Arisawa T, Artikov A, Ashmanskas W, Attal A, Aurisano A, Azfar F, Azzi-Bacchetta P, Azzurri P, Bacchetta N, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Baroiant S, Bartsch V, Bauer G, Beauchemin PH, Bedeschi F, Bednar P, Behari S, Bellettini G, Bellinger J, Belloni A, Benjamin D, Beretvas A, Beringer J, Berry T, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bolla G, Bolshov A, Bortoletto D, Boudreau J, Boveia A, Brau B, Bridgeman A, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Campanelli M, Campbell M, Canelli F, Canepa A, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Choudalakis G, Chuang SH, Chung K, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark A, Clark D, Compostella G, Convery ME, Conway J, Cooper B, Copic K, Cordelli M, Cortiana G, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Cully JC, Dagenhart D, Datta M, Davies T, de Barbaro P, De Cecco S, Deisher A, De Lentdecker G, De Lorenzo G, Dell'Orso M, Demortier L, Deng J, Deninno M, De Pedis D, Derwent PF, Di Giovanni GP, Dionisi C, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Donini J, Dorigo T, Dube S, Efron J, Erbacher R, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Forrester S, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garfinkel AF, Genser K, Gerberich H, Gerdes D, Giagu S, Giakoumopolou V, Giannetti P, Gibson K, Gimmell JL, Ginsburg CM, Giokaris N, Giordani M, Giromini P, Giunta M, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Grundler U, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hamilton A, Han BY, Han JY, Handler R, Happacher F, Hara K, Hare D, Hare M, Harper S, Harr RF, Harris RM, Hartz M, Hatakeyama K, Hauser J, Hays C, Heck M, Heijboer A, Heinemann B, Heinrich J, Henderson C, Herndon M, Heuser J, Hewamanage S, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Husemann U, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, Iyutin B, James E, Jayatilaka B, Jeans D, Jeon EJ, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Kar D, Karchin PE, Kato Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Klute M, Knuteson B, Ko BR, Koay SA, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kraus J, Kreps M, Kroll J, Krumnack N, Kruse M, Krutelyov V, Kubo T, Kuhlmann SE, Kuhr T, Kulkarni NP, Kusakabe Y, Kwang S, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, LeCompte T, Lee J, Lee J, Lee YJ, Lee SW, Lefèvre R, Leonardo N, Leone S, Levy S, Lewis JD, Lin C, Lin CS, Linacre J, Lindgren M, Lipeles E, Liss TM, Lister A, Litvintsev DO, Liu T, Lockyer NS, Loginov A, Loreti M, Lovas L, Lu RS, Lucchesi D, Lueck J, Luci C, Lujan P, Lukens P, Lungu G, Lyons L, Lys J, Lysak R, Lytken E, Mack P, MacQueen D, Madrak R, Maeshima K, Makhoul K, Maki T, Maksimovic P, Malde S, Malik S, Manca G, Manousakis A, Margaroli F, Marino C, Marino CP, Martin A, Martin M, Martin V, Martínez M, Martínez-Ballarín R, Maruyama T, Mastrandrea P, Masubuchi T, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Miao T, Miladinovic N, Miles J, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello M, Movilla Fernandez P, Mülmenstädt J, Mukherjee A, Muller T, Mumford R, Murat P, Mussini M, Nachtman J, Nagai Y, Nagano A, Naganoma J, Nakamura K, Nakano I, Napier A, Necula V, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norman M, Norniella O, Nurse E, Oh SH, Oh YD, Oksuzian I, Okusawa T, Oldeman R, Orava R, Osterberg K, Griso SP, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramonov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pinera L, Pitts K, Plager C, Pondrom L, Portell X, Poukhov O, Pounder N, Prakoshyn F, Pronko A, Proudfoot J, Ptohos F, Punzi G, Pursley J, Rademacker J, Rahaman A, Ramakrishnan V, Ranjan N, Redondo I, Reisert B, Rekovic V, Renton P, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Roy P, Ruiz A, Russ J, Rusu V, Saarikko H, Safonov A, Sakumoto WK, Salamanna G, Saltó O, Santi L, Sarkar S, Sartori L, Sato K, Savoy-Navarro A, Scheidle T, Schlabach P, Schmidt EE, Schmidt MA, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scott AL, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sfyrla A, Shalhout SZ, Shapiro MD, Shears T, Shepard PF, Sherman D, Shimojima M, Shochet M, Shon Y, Shreyber I, Sidoti A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soderberg M, Soha A, Somalwar S, Sorin V, Spalding J, Spinella F, Spreitzer T, Squillacioti P, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Stuart D, Suh JS, Sukhanov A, Sun H, Suslov I, Suzuki T, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tecchio M, Teng PK, Terashi K, Thom J, Thompson AS, Thompson GA, Thomson E, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Tourneur S, Trischuk W, Tu Y, Turini N, Ukegawa F, Uozumi S, Vallecorsa S, van Remortel N, Varganov A, Vataga E, Vázquez F, Velev G, Vellidis C, Veszpremi V, Vidal M, Vidal R, Vila I, Vilar R, Vine T, Vogel M, Volobouev I, Volpi G, Würthwein F, Wagner P, Wagner RG, Wagner RL, Wagner-Kuhr J, Wagner W, Wakisaka T, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wright T, Wu X, Wynne SM, Yagil A, Yamamoto K, Yamaoka J, Yamashita T, Yang C, Yang UK, Yang YC, Yao WM, Yeh GP, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanello L, Zanetti A, Zaw I, Zhang X, Zheng Y, Zucchelli S. Search for pair production of scalar top quarks decaying to a tau lepton and a b quark in pp over collisions at sqrt s=1.96 TeV. PHYSICAL REVIEW LETTERS 2008; 101:071802. [PMID: 18764522 DOI: 10.1103/physrevlett.101.071802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/27/2008] [Indexed: 05/26/2023]
Abstract
We search for pair production of supersymmetric top quarks (t over1), followed by R-parity violating decay t over1-->taub with a branching ratio beta, using 322 pb(-1) of pp over collisions at sqrt s=1.96 TeV collected by the upgraded Collider Detector at Fermilab. Two candidate events pass our final selection criteria, consistent with the standard model expectation. We set upper limits on the cross section sigma(t over1t over1) x beta2 as a function of the top-squark mass m(t over1). Assuming beta=1, we set a 95% confidence level limit m(t over1)>153 GeV/c2. The limits are also applicable to the case of a third-generation scalar leptoquark (LQ3) decaying LQ3-->taub.
Collapse
|
595
|
Safir O, Dubrowski A, Mirsky L, Lin C, Backstein D, Carnahan H. What skills should simulation training in arthroscopy teach residents? Int J Comput Assist Radiol Surg 2008. [DOI: 10.1007/s11548-008-0249-y] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
596
|
Aaltonen T, Abulencia A, Adelman J, Akimoto T, Albrow MG, González BA, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Apollinari G, Apresyan A, Arisawa T, Artikov A, Ashmanskas W, Attal A, Aurisano A, Azfar F, Azzi-Bacchetta P, Azzurri P, Bacchetta N, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Baroiant S, Bartsch V, Bauer G, Beauchemin PH, Bedeschi F, Bednar P, Behari S, Bellettini G, Bellinger J, Belloni A, Benjamin D, Beretvas A, Beringer J, Berry T, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bolla G, Bolshov A, Bortoletto D, Boudreau J, Boveia A, Brau B, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Campanelli M, Campbell M, Canelli F, Canepa A, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Choudalakis G, Chuang SH, Chung K, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark A, Clark D, Compostella G, Convery ME, Conway J, Cooper B, Copic K, Cordelli M, Cortiana G, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Cully JC, Dagenhart D, Datta M, Davies T, de Barbaro P, De Cecco S, Deisher A, De Lentdecker G, De Lorenzo G, Dell'orso M, Demortier L, Deng J, Deninno M, De Pedis D, Derwent PF, Di Giovanni GP, Dionisi C, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Donini J, Dorigo T, Dube S, Efron J, Erbacher R, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Forrester S, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garfinkel AF, Gerberich H, Gerdes D, Giagu S, Giannetti P, Gibson K, Gimmell JL, Ginsburg C, Giokaris N, Giordani M, Giromini P, Giunta M, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Goldstein J, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Grundler U, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hamilton A, Han BY, Han JY, Handler R, Happacher F, Hara K, Hare D, Hare M, Harper S, Harr RF, Harris RM, Hartz M, Hatakeyama K, Hauser J, Hays C, Heck M, Heijboer A, Heinemann B, Heinrich J, Henderson C, Herndon M, Heuser J, Hewamanage S, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Husemann U, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, Iyutin B, James E, Jayatilaka B, Jeans D, Jeon EJ, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Kar D, Karchin PE, Kato Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Klute M, Knuteson B, Ko BR, Koay SA, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kraus J, Kreps M, Kroll J, Krumnack N, Kruse M, Krutelyov V, Kubo T, Kuhlmann SE, Kuhr T, Kulkarni NP, Kusakabe Y, Kwang S, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, Lecompte T, Lee J, Lee J, Lee YJ, Lee SW, Lefèvre R, Leonardo N, Leone S, Levy S, Lewis JD, Lin C, Lin CS, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu T, Lockyer NS, Loginov A, Loreti M, Lovas L, Lu RS, Lucchesi D, Lueck J, Luci C, Lujan P, Lukens P, Lungu G, Lyons L, Lys J, Lysak R, Lytken E, Mack P, Macqueen D, Madrak R, Maeshima K, Makhoul K, Maki T, Maksimovic P, Malde S, Malik S, Manca G, Manousakis A, Margaroli F, Marino C, Marino CP, Martin A, Martin M, Martin V, Martínez M, Martínez-Ballarín R, Maruyama T, Mastrandrea P, Masubuchi T, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Miao T, Miladinovic N, Miles J, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello M, Movilla Fernandez P, Mülmenstädt J, Mukherjee A, Muller T, Mumford R, Murat P, Mussini M, Nachtman J, Nagai Y, Nagano A, Naganoma J, Nakamura K, Nakano I, Napier A, Necula V, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norman M, Norniella O, Nurse E, Oh SH, Oh YD, Oksuzian I, Okusawa T, Oldeman R, Orava R, Osterberg K, Pagan Griso S, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramonov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pinera L, Pitts K, Plager C, Pondrom L, Portell X, Poukhov O, Pounder N, Prakoshyn F, Pronko A, Proudfoot J, Ptohos F, Punzi G, Pursley J, Rademacker J, Rahaman A, Ramakrishnan V, Ranjan N, Redondo I, Reisert B, Rekovic V, Renton P, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Roy P, Ruiz A, Russ J, Rusu V, Saarikko H, Safonov A, Sakumoto WK, Salamanna G, Saltó O, Santi L, Sarkar S, Sartori L, Sato K, Savard P, Savoy-Navarro A, Scheidle T, Schlabach P, Schmidt EE, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scott AL, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sfyrla A, Shalhout SZ, Shapiro MD, Shears T, Shepard PF, Sherman D, Shimojima M, Shochet M, Shon Y, Shreyber I, Sidoti A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soderberg M, Soha A, Somalwar S, Sorin V, Spalding J, Spinella F, Spreitzer T, Squillacioti P, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Stuart D, Suh JS, Sukhanov A, Sun H, Suslov I, Suzuki T, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tecchio M, Teng PK, Terashi K, Thom J, Thompson AS, Thompson GA, Thomson E, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Tourneur S, Trischuk W, Tu Y, Turini N, Ukegawa F, Uozumi S, Vallecorsa S, van Remortel N, Varganov A, Vataga E, Vázquez F, Velev G, Vellidis C, Veszpremi V, Vidal M, Vidal R, Vila I, Vilar R, Vine T, Vogel M, Volobouev I, Volpi G, Würthwein F, Wagner P, Wagner RG, Wagner RL, Wagner J, Wagner W, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wright T, Wu X, Wynne SM, Yagil A, Yamamoto K, Yamaoka J, Yamashita T, Yang C, Yang UK, Yang YC, Yao WM, Yeh GP, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanello L, Zanetti A, Zaw I, Zhang X, Zheng Y, Zucchelli S. Search for resonant tt[overline] production in pp[overline] collisions at sqrt[s]=1.96 TeV. PHYSICAL REVIEW LETTERS 2008; 100:231801. [PMID: 18643483 DOI: 10.1103/physrevlett.100.231801] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2007] [Indexed: 05/26/2023]
Abstract
We report on a search for narrow-width particles decaying to a top and antitop quark pair. The data set used in the analysis corresponds to an integrated luminosity of 680 pb(-1) collected with the Collider Detector at Fermilab in run II. We present 95% confidence level upper limits on the cross section times branching ratio. Assuming a specific top-color-assisted technicolor production model, the leptophobic Z' with width Gamma(Z')=0.012M(Z'), we exclude the mass range M(Z')<725 GeV/c(2) at the 95% confidence level.
Collapse
|
597
|
Aaltonen T, Adelman J, Akimoto T, Albrow MG, Alvarez González B, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Aoki M, Apollinari G, Apresyan A, Arisawa T, Artikov A, Ashmanskas W, Attal A, Aurisano A, Azfar F, Azzi-Bacchetta P, Azzurri P, Bacchetta N, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Baroiant S, Bartsch V, Bauer G, Beauchemin PH, Bedeschi F, Bednar P, Behari S, Bellettini G, Bellinger J, Belloni A, Benjamin D, Beretvas A, Beringer J, Berry T, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bolla G, Bolshov A, Bortoletto D, Boudreau J, Boveia A, Brau B, Bridgeman A, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Campanelli M, Campbell M, Canelli F, Canepa A, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Choudalakis G, Chuang SH, Chung K, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark A, Clark D, Compostella G, Convery ME, Conway J, Cooper B, Copic K, Cordelli M, Cortiana G, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Cully JC, Dagenhart D, Datta M, Davies T, de Barbaro P, De Cecco S, Deisher A, De Lentdecker G, De Lorenzo G, Dell'Orso M, Demortier L, Deng J, Deninno M, De Pedis D, Derwent PF, Di Giovanni GP, Dionisi C, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Donini J, Dorigo T, Dube S, Efron J, Erbacher R, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Forrester S, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garfinkel AF, Genser K, Gerberich H, Gerdes D, Giagu S, Giakoumopolou V, Giannetti P, Gibson K, Gimmell JL, Ginsburg CM, Giokaris N, Giordani M, Giromini P, Giunta M, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Grundler U, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hamilton A, Han BY, Han JY, Handler R, Happacher F, Hara K, Hare D, Hare M, Harper S, Harr RF, Harris RM, Hartz M, Hatakeyama K, Hauser J, Hays C, Heck M, Heijboer A, Heinemann B, Heinrich J, Henderson C, Herndon M, Heuser J, Hewamanage S, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Husemann U, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, Iyutin B, James E, Jayatilaka B, Jeans D, Jeon EJ, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Kar D, Karchin PE, Kato Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Klute M, Knuteson B, Ko BR, Koay SA, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kraus J, Kreps M, Kroll J, Krumnack N, Kruse M, Krutelyov V, Kubo T, Kuhlmann SE, Kuhr T, Kulkarni NP, Kusakabe Y, Kwang S, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, LeCompte T, Lee J, Lee J, Lee YJ, Lee SW, Lefèvre R, Leonardo N, Leone S, Levy S, Lewis JD, Lin C, Lin CS, Linacre J, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu T, Lockyer NS, Loginov A, Loreti M, Lovas L, Lu RS, Lucchesi D, Lueck J, Luci C, Lujan P, Lukens P, Lungu G, Lyons L, Lys J, Lysak R, Lytken E, Mack P, Macqueen D, Madrak R, Maeshima K, Makhoul K, Maki T, Maksimovic P, Malde S, Malik S, Manca G, Manousakis A, Margaroli F, Marino C, Marino CP, Martin A, Martin M, Martin V, Martínez M, Martínez-Ballarín R, Maruyama T, Mastrandrea P, Masubuchi T, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Miao T, Miladinovic N, Miles J, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello M, Movilla Fernandez P, Mülmenstädt J, Mukherjee A, Muller T, Mumford R, Murat P, Mussini M, Nachtman J, Nagai Y, Nagano A, Naganoma J, Nakamura K, Nakano I, Napier A, Necula V, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norman M, Norniella O, Nurse E, Oh SH, Oh YD, Oksuzian I, Okusawa T, Oldeman R, Orava R, Osterberg K, Pagan Griso S, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramonov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pinera L, Pitts K, Plager C, Pondrom L, Portell X, Poukhov O, Pounder N, Prakoshyn F, Pronko A, Proudfoot J, Ptohos F, Punzi G, Pursley J, Rademacker J, Rahaman A, Ramakrishnan V, Ranjan N, Redondo I, Reisert B, Rekovic V, Renton P, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Rott C, Roy P, Ruiz A, Russ J, Rusu V, Saarikko H, Safonov A, Sakumoto WK, Salamanna G, Saltó O, Santi L, Sarkar S, Sartori L, Sato K, Savoy-Navarro A, Scheidle T, Schlabach P, Schmidt EE, Schmidt MA, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scott AL, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sfyrla A, Shalhout SZ, Shapiro MD, Shears T, Shepard PF, Sherman D, Shimojima M, Shochet M, Shon Y, Shreyber I, Sidoti A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soderberg M, Soha A, Somalwar S, Sorin V, Spalding J, Spinella F, Spreitzer T, Squillacioti P, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Stuart D, Suh JS, Sukhanov A, Sun H, Suslov I, Suzuki T, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tecchio M, Teng PK, Terashi K, Thom J, Thompson AS, Thompson GA, Thomson E, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Tourneur S, Trischuk W, Tu Y, Turini N, Ukegawa F, Uozumi S, Vallecorsa S, van Remortel N, Varganov A, Vataga E, Vázquez F, Velev G, Vellidis C, Veszpremi V, Vidal M, Vidal R, Vila I, Vilar R, Vine T, Vogel M, Volobouev I, Volpi G, Würthwein F, Wagner P, Wagner RG, Wagner RL, Wagner-Kuhr J, Wagner W, Wakisaka T, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wright T, Wu X, Wynne SM, Yagil A, Yamamoto K, Yamaoka J, Yamashita T, Yang C, Yang UK, Yang YC, Yao WM, Yeh GP, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanello L, Zanetti A, Zaw I, Zhang X, Zheng Y, Zucchelli S. Search for the Higgs boson in events with missing transverse energy and b quark jets produced in pp collisions at square root(s)=1.96 TeV. PHYSICAL REVIEW LETTERS 2008; 100:211801. [PMID: 18518598 DOI: 10.1103/physrevlett.100.211801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2008] [Indexed: 05/26/2023]
Abstract
We search for the standard model Higgs boson produced in association with an electroweak vector boson in events with no identified charged leptons, large imbalance in transverse momentum, and two jets where at least one contains a secondary vertex consistent with the decay of b hadrons. We use approximately 1 fb(-1) integrated luminosity of pp collisions at square root(s)=1.96 TeV recorded by the Collider Detector at Fermilab II experiment at the Tevatron. We find 268 (16) single (double) b-tagged candidate events, where 248+/-43 (14.4+/-2.7) are expected from standard model background processes. We observe no significant excess over the expected background and thus set 95% confidence level upper limits on the Higgs boson production cross section for several Higgs boson masses ranging from 110 to 140 GeV/c(2). For a mass of 115 GeV/c(2), the observed (expected) limit is 20.4 (14.2) times the standard model prediction.
Collapse
|
598
|
Aaltonen T, Abulencia A, Adelman J, Affolder T, Akimoto T, Albrow MG, Amerio S, Amidei D, Anastassov A, Anikeev K, Annovi A, Antos J, Aoki M, Apollinari G, Arisawa T, Artikov A, Ashmanskas W, Attal A, Aurisano A, Azfar F, Azzi-Bacchetta P, Azzurri P, Bacchetta N, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Baroiant S, Bartsch V, Bauer G, Beauchemin PH, Bedeschi F, Behari S, Bellettini G, Bellinger J, Belloni A, Benjamin D, Beretvas A, Beringer J, Berry T, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bolla G, Bolshov A, Bortoletto D, Boudreau J, Boveia A, Brau B, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Campanelli M, Campbell M, Canelli F, Canepa A, Carrillo S, Carlsmith D, Carosi R, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho I, Cho K, Chokheli D, Chou JP, Choudalakis G, Chuang SH, Chung K, Chung WH, Chung YS, Cilijak M, Ciobanu CI, Ciocci MA, Clark A, Clark D, Coca M, Compostella G, Convery ME, Conway J, Cooper B, Copic K, Cordelli M, Cortiana G, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Cully JC, DaRonco S, Datta M, D’Auria S, Davies T, Dagenhart D, de Barbaro P, De Cecco S, Deisher A, De Lentdecker G, De Lorenzo G, Dell’Orso M, Delli Paoli F, Demortier L, Deng J, Deninno M, De Pedis D, Derwent PF, Di Giovanni GP, Dionisi C, Di Ruzza B, Dittmann JR, D’Onofrio M, Dörr C, Donati S, Dong P, Donini J, Dorigo T, Dube S, Efron J, Erbacher R, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko I, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Field R, Flanagan G, Forrest R, Forrester S, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garcia JE, Garberson F, Garfinkel AF, Gay C, Gerberich H, Gerdes D, Giagu S, Giannetti P, Gibson K, Gimmell JL, Ginsburg C, Giokaris N, Giordani M, Giromini P, Giunta M, Giurgiu G, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Goldstein J, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Group RC, Grundler U, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hamilton A, Han BY, Han JY, Handler R, Happacher F, Hara K, Hare D, Hare M, Harper S, Harr RF, Harris RM, Hartz M, Hatakeyama K, Hauser J, Hays C, Heck M, Heijboer A, Heinemann B, Heinrich J, Henderson C, Herndon M, Heuser J, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Holloway A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Husemann U, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, Iyutin B, James E, Jang D, Jayatilaka B, Jeans D, Jeon EJ, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Karchin PE, Kato Y, Kemp Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Klute M, Knuteson B, Ko BR, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kraan AC, Kraus J, Kreps M, Kroll J, Krumnack N, Kruse M, Krutelyov V, Kubo T, Kuhlmann SE, Kuhr T, Kulkarni NP, Kusakabe Y, Kwang S, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, LeCompte T, Lee J, Lee J, Lee YJ, Lee SW, Lefèvre R, Leonardo N, Leone S, Levy S, Lewis JD, Lin C, Lin CS, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu T, Lockyer NS, Loginov A, Loreti M, Lu RS, Lucchesi D, Lujan P, Lukens P, Lungu G, Lyons L, Lys J, Lysak R, Lytken E, Mack P, MacQueen D, Madrak R, Maeshima K, Makhoul K, Maki T, Maksimovic P, Malde S, Malik S, Manca G, Manousakis A, Margaroli F, Marginean R, Marino C, Marino CP, Martin A, Martin M, Martin V, Martínez M, Martínez-Ballarín R, Maruyama T, Mastrandrea P, Masubuchi T, Matsunaga H, Mattson ME, Mazini R, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Miao T, Miladinovic N, Miles J, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyamoto A, Moed S, Moggi N, Mohr B, Moon CS, Moore R, Morello M, Movilla Fernandez P, Mülmenstädt J, Mukherjee A, Muller T, Mumford R, Murat P, Mussini M, Nachtman J, Nagano A, Naganoma J, Nakamura K, Nakano I, Napier A, Necula V, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norniella O, Nurse E, Oh SH, Oh YD, Oksuzian I, Okusawa T, Oldeman R, Orava R, Osterberg K, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramonov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pinera L, Pitts K, Plager C, Pondrom L, Portell X, Poukhov O, Pounder N, Prakoshyn F, Pronko A, Proudfoot J, Ptohos F, Punzi G, Pursley J, Rademacker J, Rahaman A, Ramakrishnan V, Ranjan N, Redondo I, Reisert B, Rekovic V, Renton P, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Roy P, Ruiz A, Russ J, Rusu V, Saarikko H, Safonov A, Sakumoto WK, Salamanna G, Saltó O, Santi L, Sarkar S, Sartori L, Sato K, Savard P, Savoy-Navarro A, Scheidle T, Schlabach P, Schmidt EE, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scott AL, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sfyrla A, Shalhout SZ, Shapiro MD, Shears T, Shepard PF, Sherman D, Shimojima M, Shochet M, Shon Y, Shreyber I, Sidoti A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soderberg M, Soha A, Somalwar S, Sorin V, Spalding J, Spinella F, Spreitzer T, Squillacioti P, Stanitzki M, Staveris-Polykalas A, St. Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Stuart D, Suh JS, Sukhanov A, Sun H, Suslov I, Suzuki T, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tecchio M, Teng PK, Terashi K, Thom J, Thompson AS, Thomson E, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Tourneur S, Trischuk W, Tsuno S, Tu Y, Turini N, Ukegawa F, Uozumi S, Vallecorsa S, van Remortel N, Varganov A, Vataga E, Vazquez F, Velev G, Vellidis C, Veramendi G, Veszpremi V, Vidal M, Vidal R, Vila I, Vilar R, Vine T, Vogel M, Vollrath I, Volobouev I, Volpi G, Würthwein F, Wagner P, Wagner RG, Wagner RL, Wagner J, Wagner W, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wright T, Wu X, Wynne SM, Yagil A, Yamamoto K, Yamaoka J, Yamashita T, Yang C, Yang UK, Yang YC, Yao WM, Yeh GP, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanello L, Zanetti A, Zaw I, Zhang X, Zhou J, Zucchelli S. Search for third generation vector leptoquarks inpp¯collisions ats=1.96 TeV. Int J Clin Exp Med 2008. [DOI: 10.1103/physrevd.77.091105] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
599
|
Aaltonen T, Adelman J, Akimoto T, Albrow MG, Alvarez González B, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, Aoki M, Apollinari G, Apresyan A, Arisawa T, Artikov A, Ashmanskas W, Attal A, Aurisano A, Azfar F, Azzi-Bacchetta P, Azzurri P, Bacchetta N, Badgett W, Barbaro-Galtieri A, Barnes VE, Barnett BA, Baroiant S, Bartsch V, Bauer G, Beauchemin PH, Bedeschi F, Bednar P, Behari S, Bellettini G, Bellinger J, Belloni A, Benjamin D, Beretvas A, Beringer J, Berry T, Bhatti A, Binkley M, Bisello D, Bizjak I, Blair RE, Blocker C, Blumenfeld B, Bocci A, Bodek A, Boisvert V, Bolla G, Bolshov A, Bortoletto D, Boudreau J, Boveia A, Brau B, Bridgeman A, Brigliadori L, Bromberg C, Brubaker E, Budagov J, Budd HS, Budd S, Burkett K, Busetto G, Bussey P, Buzatu A, Byrum KL, Cabrera S, Campanelli M, Campbell M, Canelli F, Canepa A, Carlsmith D, Carosi R, Carrillo S, Carron S, Casal B, Casarsa M, Castro A, Catastini P, Cauz D, Cavalli-Sforza M, Cerri A, Cerrito L, Chang SH, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chou JP, Choudalakis G, Chuang SH, Chung K, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark A, Clark D, Compostella G, Convery ME, Conway J, Cooper B, Copic K, Cordelli M, Cortiana G, Crescioli F, Cuenca Almenar C, Cuevas J, Culbertson R, Cully JC, Dagenhart D, Datta M, Davies T, de Barbaro P, De Cecco S, Deisher A, De Lentdecker G, De Lorenzo G, Dell'Orso M, Demortier L, Deng J, Deninno M, De Pedis D, Derwent PF, Di Giovanni GP, Dionisi C, Di Ruzza B, Dittmann JR, D'Onofrio M, Donati S, Dong P, Donini J, Dorigo T, Dube S, Efron J, Erbacher R, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko WT, Feild RG, Feindt M, Fernandez JP, Ferrazza C, Field R, Flanagan G, Forrest R, Forrester S, Franklin M, Freeman JC, Furic I, Gallinaro M, Galyardt J, Garberson F, Garcia JE, Garfinkel AF, Genser K, Gerberich H, Gerdes D, Giagu S, Giakoumopolou V, Giannetti P, Gibson K, Gimmell JL, Ginsburg CM, Giokaris N, Giordani M, Giromini P, Giunta M, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Golossanov A, Gomez G, Gomez-Ceballos G, Goncharov M, González O, Gorelov I, Goshaw AT, Goulianos K, Gresele A, Grinstein S, Grosso-Pilcher C, Grundler U, Guimaraes da Costa J, Gunay-Unalan Z, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hamilton A, Han BY, Han JY, Handler R, Happacher F, Hara K, Hare D, Hare M, Harper S, Harr RF, Harris RM, Hartz M, Hatakeyama K, Hauser J, Hays C, Heck M, Heijboer A, Heinemann B, Heinrich J, Henderson C, Herndon M, Heuser J, Hewamanage S, Hidas D, Hill CS, Hirschbuehl D, Hocker A, Hou S, Houlden M, Hsu SC, Huffman BT, Hughes RE, Husemann U, Huston J, Incandela J, Introzzi G, Iori M, Ivanov A, Iyutin B, James E, Jayatilaka B, Jeans D, Jeon EJ, Jindariani S, Johnson W, Jones M, Joo KK, Jun SY, Jung JE, Junk TR, Kamon T, Kar D, Karchin PE, Kato Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim DH, Kim HS, Kim JE, Kim MJ, Kim SB, Kim SH, Kim YK, Kimura N, Kirsch L, Klimenko S, Klute M, Knuteson B, Ko BR, Koay SA, Kondo K, Kong DJ, Konigsberg J, Korytov A, Kotwal AV, Kraus J, Kreps M, Kroll J, Krumnack N, Kruse M, Krutelyov V, Kubo T, Kuhlmann SE, Kuhr T, Kulkarni NP, Kusakabe Y, Kwang S, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster M, Lander RL, Lannon K, Lath A, Latino G, Lazzizzera I, LeCompte T, Lee J, Lee J, Lee YJ, Lee SW, Lefèvre R, Leonardo N, Leone S, Levy S, Lewis JD, Lin C, Lin CS, Linacre J, Lindgren M, Lipeles E, Lister A, Litvintsev DO, Liu T, Lockyer NS, Loginov A, Loreti M, Lovas L, Lu RS, Lucchesi D, Lueck J, Luci C, Lujan P, Lukens P, Lungu G, Lyons L, Lys J, Lysak R, Lytken E, Mack P, MacQueen D, Madrak R, Maeshima K, Makhoul K, Maki T, Maksimovic P, Malde S, Malik S, Manca G, Manousakis A, Margaroli F, Marino C, Marino CP, Martin A, Martin M, Martin V, Martínez M, Martínez-Ballarín R, Maruyama T, Mastrandrea P, Masubuchi T, Mattson ME, Mazzanti P, McFarland KS, McIntyre P, McNulty R, Mehta A, Mehtala P, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Miao T, Miladinovic N, Miles J, Miller R, Mills C, Milnik M, Mitra A, Mitselmakher G, Miyake H, Moed S, Moggi N, Moon CS, Moore R, Morello M, Movilla Fernandez P, Mülmenstädt J, Mukherjee A, Muller T, Mumford R, Murat P, Mussini M, Nachtman J, Nagai Y, Nagano A, Naganoma J, Nakamura K, Nakano I, Napier A, Necula V, Neu C, Neubauer MS, Nielsen J, Nodulman L, Norman M, Norniella O, Nurse E, Oh SH, Oh YD, Oksuzian I, Okusawa T, Oldeman R, Orava R, Osterberg K, Pagan Griso S, Pagliarone C, Palencia E, Papadimitriou V, Papaikonomou A, Paramonov AA, Parks B, Pashapour S, Patrick J, Pauletta G, Paulini M, Paus C, Pellett DE, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pinera L, Pitts K, Plager C, Pondrom L, Portell X, Poukhov O, Pounder N, Prakoshyn F, Pronko A, Proudfoot J, Ptohos F, Punzi G, Pursley J, Rademacker J, Rahaman A, Ramakrishnan V, Ranjan N, Redondo I, Reisert B, Rekovic V, Renton P, Rescigno M, Richter S, Rimondi F, Ristori L, Robson A, Rodrigo T, Rogers E, Rolli S, Roser R, Rossi M, Rossin R, Roy P, Ruiz A, Russ J, Rusu V, Saarikko H, Safonov A, Sakumoto WK, Salamanna G, Saltó O, Santi L, Sarkar S, Sartori L, Sato K, Savoy-Navarro A, Scheidle T, Schlabach P, Schmidt EE, Schmidt MA, Schmidt MP, Schmitt M, Schwarz T, Scodellaro L, Scott AL, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semenov A, Sexton-Kennedy L, Sfyrla A, Shalhout SZ, Shapiro MD, Shears T, Shepard PF, Sherman D, Shimojima M, Shochet M, Shon Y, Shreyber I, Sidoti A, Sinervo P, Sisakyan A, Slaughter AJ, Slaunwhite J, Sliwa K, Smith JR, Snider FD, Snihur R, Soderberg M, Soha A, Somalwar S, Sorin V, Spalding J, Spinella F, Spreitzer T, Squillacioti P, Stanitzki M, St Denis R, Stelzer B, Stelzer-Chilton O, Stentz D, Strologas J, Stuart D, Suh JS, Sukhanov A, Sun H, Suslov I, Suzuki T, Taffard A, Takashima R, Takeuchi Y, Tanaka R, Tecchio M, Teng PK, Terashi K, Thom J, Thompson AS, Thompson GA, Thomson E, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tokar S, Tollefson K, Tomura T, Tonelli D, Torre S, Torretta D, Tourneur S, Trischuk W, Tu Y, Turini N, Ukegawa F, Uozumi S, Vallecorsa S, van Remortel N, Varganov A, Vataga E, Vázquez F, Velev G, Vellidis C, Veszpremi V, Vidal M, Vidal R, Vila I, Vilar R, Vine T, Vogel M, Volobouev I, Volpi G, Würthwein F, Wagner P, Wagner RG, Wagner RL, Wagner-Kuhr J, Wagner W, Wakisaka T, Wallny R, Wang SM, Warburton A, Waters D, Weinberger M, Wester WC, Whitehouse B, Whiteson D, Wicklund AB, Wicklund E, Williams G, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolfe C, Wright T, Wu X, Wynne SM, Yagil A, Yamamoto K, Yamaoka J, Yamashita T, Yang C, Yang UK, Yang YC, Yao WM, Yeh GP, Yoh J, Yorita K, Yoshida T, Yu GB, Yu I, Yu SS, Yun JC, Zanello L, Zanetti A, Zaw I, Zhang X, Zheng Y, Zucchelli S, Group RC. Strong evidence for ZZ production in pp[over] collisions at sqrt[s]=1.96 TeV. PHYSICAL REVIEW LETTERS 2008; 100:201801. [PMID: 18518523 DOI: 10.1103/physrevlett.100.201801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/01/2008] [Indexed: 05/26/2023]
Abstract
We report the first evidence of Z boson pair production at a hadron collider with a significance exceeding 4 standard deviations. This result is based on a data sample corresponding to 1.9 fb(-1) of integrated luminosity from pp[over] collisions at sqrt[s]=1.96 TeV collected with the Collider Detector at Fermilab II detector. In the lll'l' channel, we observe three ZZ candidates with an expected background of 0.096(-0.063)+0.092 events. In the llnunu channel, we use a leading-order calculation of the relative ZZ and WW event probabilities to discriminate between signal and background. In the combination of lll'l' and llnunu channels, we observe an excess of events with a probability of 5.1 x 10(-6) to be due to the expected background. This corresponds to a significance of 4.4 standard deviations. The measured cross section is sigma(pp[over]-->ZZ)=1.4(-0.6)+0.7(stat+syst) pb, consistent with the standard model expectation.
Collapse
|
600
|
Lo J, Lin C, Tzen K, Cheng JC, Hsu F, Tsai Y, Huang T, Yeh K, Lee Y, Hsu C. Assessment of early metabolic response to one-cycle chemotherapy by PET in locally advanced esophageal squamous cell carcinoma (ESCC) treated with chemoradiotherapy (CRT) followed by surgery-A pilot study. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.15610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|